L226Q Mutation on Influenza H7N9 Virus Hemagglutinin Increases Receptor-Binding Avidity and Leads to Biased Antigenicity Evaluation

Yang Wang,Yunhua Lv,Xuefeng Niu,Ji Dong,Pei Feng,Qinming Li,Wei Xu,Jiashun Li,Chufang Li,Jiahui Li,Jia Luo,Zhixia Li,Yichu Liu,Yee-Joo Tan,Weiqi Pan,Ling Chen
DOI: https://doi.org/10.1128/jvi.00667-20
IF: 6.549
2020-09-29
Journal of Virology
Abstract:The HI assay is a standard method for profiling the antigenic characterization of influenza viruses. Suspected antigenic changes based on HI divergency in H7N9 viruses during the 2016-2017 wave prompted the recommendation of new H7N9 candidate vaccine viruses (CVVs). In this study, we found that the L226Q substitution in HA of A/Guangdong/17SF003/2016 (H7/GD16) increased the viral receptor-binding avidity to red blood cells with no impact on the antigenicity of H7N9 virus. Although immune sera raised by an earlier vaccine strain (H7/AH13) showed poor HI titers against H7/GD16, the H7/AH13 immune sera had potent cross-neutralizing antibody titers against H7/GD16 and could provide complete passive protection against H7N9/GD16 virus challenge in mice. Our study highlights that receptor-binding avidity might lead to biased antigenic evaluation by using the HI assay. Other serological assays, such as the microneutralization (MN) assay, should be considered a complementary indicator for analysis of antigenic variation and selection of influenza CVVs.
virology
What problem does this paper attempt to address?